Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-09-08
1988-02-16
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, 544278, 544250, 549 71, C07D49504, C07D49704, A61K 31505
Patent
active
047255994
ABSTRACT:
Certain trans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]thieno[3,2-d]pyrimidin-4(3H )-one and furo[3,2-d]pyrimidin-4(3H)-one derivatives, a method of using same as anticoccidial agents, intermediates therefor, and a process for certain intermediates therefor.
REFERENCES:
patent: Re26833 (1970-03-01), Waletzky et al.
patent: 2651632 (1953-09-01), Baker et al.
patent: 3318881 (1967-05-01), Ohnacker et al.
patent: 3320124 (1967-05-01), Waletzky et al.
patent: 3706747 (1972-12-01), DeAngelis et al.
patent: 4239888 (1980-12-01), Miller
patent: 4376121 (1983-03-01), Kienzle
patent: 4632926 (1986-12-01), Giarda et al.
Monograph Nos. 3881 and 4479, The Merck Index, Tenth Edition.
Huddleston et al., Synthetic Communications 9 (8), 731-734 (1979).
Glazer Edward A.
McFarland James W.
Blackwood Robert K.
Cassatt Barbara
Daus Donald G.
Frost Albert E.
Pfizer Inc.
LandOfFree
Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2221358